Form 4: GLRE Director Sells Shares Under 10b5-1 Plan
Insider Transaction Report
Greenlight Capital Re Director Ian Isaacs sold 8,393 ordinary shares for a weighted average price of $12.79 on September 17, 2025, under a pre-scheduled 10b5-1 plan.
Summary
- Ian Isaacs, a Director of Greenlight Capital Re, Ltd. (GLRE), reported a sale of ordinary shares.
- The transaction involved the disposition of 8,393 ordinary shares on September 17, 2025.
- This transaction was made pursuant to a Rule 10b5-1(c) plan, indicating it was a pre-scheduled sale.
- The shares were sold at a weighted average price of $12.79, with individual trades ranging from $12.79 to $12.82.
- Following this transaction, Ian Isaacs directly beneficially owns 71,137 ordinary shares.
- Additionally, Isaacs indirectly beneficially owns 25,000 ordinary shares through the Isaacs Living Trust and 25,000 ordinary shares through the Ian Isaacs IRA.
Sentiment
Score: 5
Explanation: The sale of shares by a director is generally a neutral to slightly negative event. However, the explicit mention that the transaction was made pursuant to a Rule 10b5-1(c) plan mitigates the negative signal, as these are pre-scheduled sales not based on recent material non-public information. The director still retains significant holdings.
Negatives
- While the sale was pre-planned, any reduction in insider ownership can sometimes be perceived with caution by the market, even if not indicative of a lack of confidence.
Future Outlook
NA
Industry Context
This insider selling event is specific to Greenlight Capital Re and its director, Ian Isaacs. While not directly indicative of broader industry trends, significant insider selling across the reinsurance sector could signal concerns about future profitability or capital adequacy. However, this single transaction, especially under a 10b5-1 plan, does not provide enough information to draw such conclusions for the wider industry.
Stakeholder Impact
- Shareholders may note the reduction in direct insider ownership, though the pre-planned nature of the sale under a 10b5-1 plan suggests it is not based on new, negative information.
Key Dates
| Date | Description |
|---|---|
| 09/17/2025 | Date of earliest transaction (sale of ordinary shares) |
| 09/19/2025 | Date the Form 4 was signed and filed |
Recommendation
holdThe sale of shares by Director Ian Isaacs was conducted under a Rule 10b5-1(c) plan, indicating it was a pre-scheduled transaction rather than a discretionary sale based on new information. This mitigates the typical negative signal associated with insider selling. While the director's direct holdings are reduced, the overall beneficial ownership remains substantial. Therefore, a 'hold' recommendation is appropriate, as this transaction alone does not provide a strong enough signal for a 'buy' or 'sell' decision.
Keywords
Greenlight Capital Re, GLRE, Ian Isaacs, Director, Insider Sale, Form 4, 10b5-1 Plan, Share Disposition, Equity Transaction
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.